Showing results (551-560 of 616) with videos related to

Sort By:
Pageof 62
Annals of Neurosciences|September 24, 2021
What We Fail to See in Neuro-Genetic Diseases: A Bird's Eye View from the Developing WorldNavami Samaranayake, Pulasthi Dissanayaka, Isuru Gunarathna, et al.
Veterinary Pathology|January 22, 2000
Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumorsM H Jaffe, G Hosgood, H W Taylor, et al.
Cancer Research|August 15, 1992
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
The American Journal of the Medical Sciences|March 1, 1994
The G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the C-MYC and C-HA-RAS genes in regenerating liverV W Campbell, D Davin, S Thomas, et al.
The Journal of Biological Chemistry|September 14, 2001
Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotidesX Xu, F Hamhouyia, S D Thomas, et al.
Frontiers in Molecular Neuroscience|January 27, 2025
Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targetsNalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
The Journal of Infectious Diseases|July 23, 2016
HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell ResponsesDaniela Weiskopf, Michael A Angelo, Alba Grifoni, et al.
Journal of Virology|October 17, 2014
The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopesDaniela Weiskopf, Michael A Angelo, Derek J Bangs, et al.
European Journal of Human Genetics : EJHG|January 22, 2024
Diagnostic outcome of pro bono neurogenetic diagnostic service in Sri Lanka: A wealth creationLakmal Gonawala, Nalaka Wijekoon, Darshika Attanayake, et al.
Pageof 62